Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950149-07-000084
Filing Date
2007-03-05
Accepted
2007-03-05 17:29:18
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f27756e10vk.htm 10-K 983245
2 EXHIBIT 10.12 f27756exv10w12.htm EX-10.12 102138
3 EXHIBIT 10.13(I) f27756exv10w13xiy.htm EX-10.13(I) 18922
4 EXHIBIT 10.13(II) f27756exv10w13xiiy.htm EX-10.13(II) 22572
5 EXHIBIT 23.1 f27756exv23w1.htm EX-23.1 10020
6 EXHIBIT 31.1 f27756exv31w1.htm EX-31.1 15632
7 EXHIBIT 32.1 f27756exv32w1.htm EX-32.1 4983
8 GRAPHIC f27756f2775610.gif GRAPHIC 5346
  Complete submission text file 0000950149-07-000084.txt   1166431
Mailing Address 2100 POWELL STREET EMERYVILLE CA 94608
Business Address 2100 POWELL STREET EMERYVILLE CA 94608 5105976500
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28298 | Film No.: 07672388
SIC: 2836 Biological Products, (No Diagnostic Substances)